Artusa, F., Lamatsch, S., Phan, M. D., Özdirik, B., Berger, H., Egerer, M., et al. (2025). Soluble urokinase plasminogen activator receptor predicts survival and hepatic decompensation in advanced hepatocellular carcinoma. Liver International, 45(6). https://doi.org/10.1111/liv.70121

Bahrami, H. S. Z., Jørgensen, P. G., Hove, J. D., Dixen, U., Rasmussen, L. J. H., Eugen-Olsen, J., et al. (2025). Soluble urokinase plasminogen activator receptor and interleukin‐6 improves prediction of all‐cause mortality and major adverse cardiovascular events in Type 1 diabetes. Journal of Internal Medicine, 298(3), 188–199. https://doi.org/10.1111/joim.20108

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blasi, F., & Carmeliet, P. (2002). uPAR: A versatile signalling orchestrator. Nature Reviews Molecular Cell Biology, 3(12), 932–943. https://doi.org/10.1038/nrm977

Article  CAS  PubMed  Google Scholar 

Campbell, I. L., Hofer, M. J., & Pagenstecher, A. (2010). Transgenic models for cytokine-induced neurological disease. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1802(10), 903–917. https://doi.org/10.1016/j.bbadis.2009.10.004

Article  CAS  Google Scholar 

De Almeida, S. M., Rotta, I., Tang, B., Umlauf, A., Vaida, F., Cherner, M., et al. (2022). Higher cerebrospinal fluid soluble urokinase-type plasminogen activator receptor, but not interferon γ-inducible protein 10, correlate with higher working memory deficits. JAIDS Journal of Acquired Immune Deficiency Syndromes, 90(1), 106–114. https://doi.org/10.1097/QAI.0000000000002924

Article  CAS  PubMed  PubMed Central  Google Scholar 

Desmedt, S., Desmedt, V., Delanghe, J. R., Speeckaert, R., & Speeckaert, M. M. (2017). The intriguing role of soluble urokinase receptor in inflammatory diseases. Critical Reviews in Clinical Laboratory Sciences, 54(2), 117–133. https://doi.org/10.1080/10408363.2016.1269310

Article  CAS  PubMed  Google Scholar 

Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., et al. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832. https://doi.org/10.1038/s41591-019-0675-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galea, I. (2021). The blood–brain barrier in systemic infection and inflammation. Cellular & Molecular Immunology, 18(11), 2489–2501. https://doi.org/10.1038/s41423-021-00757-x

Article  CAS  Google Scholar 

Gianella, S., Letendre, S. L., Iudicello, J., Franklin, D., Gaufin, T., Zhang, Y., et al. (2019). Plasma (1 → 3)-β-d-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: A CHARTER analysis. Journal of NeuroVirology, 25(6), 837–843. https://doi.org/10.1007/s13365-019-00775-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guduguntla, B. A., Vasbinder, A., Anderson, E., Azam, T. U., Blakely, P., Webster, N. J., et al. (2024). Biomarkers of chronic inflammation and cognitive decline: A prospective observational study. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.12568

Article  Google Scholar 

Haupt, T. H., Kallemose, T., Ladelund, S., Rasmussen, L. J. H., Thorball, C. W., Andersen, O., et al. (2014). Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomarker Insights, 9, Article BMI.S19876. https://doi.org/10.4137/BMI.S19876

Article  Google Scholar 

Hayek, S. S., Leaf, D. E., Samman Tahhan, A., Raad, M., Sharma, S., Waikar, S. S., et al. (2020). Soluble urokinase receptor and acute kidney injury. The New England Journal of Medicine, 382(5), 416–426. https://doi.org/10.1056/NEJMoa1911481

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodges, G. W., Bang, C. N., Wachtell, K., Eugen-Olsen, J., & Jeppesen, J. L. (2015). suPAR: A new biomarker for cardiovascular disease? Canadian Journal of Cardiology, 31(10), 1293–1302. https://doi.org/10.1016/j.cjca.2015.03.023

Article  PubMed  Google Scholar 

Hynes, R. O. (2009). The extracellular matrix: Not just pretty fibrils. Science, 326(5957), 1216–1219. https://doi.org/10.1126/science.1176009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jo, M., Takimoto, S., Montel, V., & Gonias, S. L. (2009). The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. The American Journal of Pathology, 175(1), 190–200. https://doi.org/10.2353/ajpath.2009.081053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khan, M. M., Bradford, H. N., Isordia-Salas, I., Liu, Y., Wu, Y., Espinola, R. G., et al. (2006). Mac-1, and gC1qR in Monocytes. Arteriosclerosis Thrombosis and Vascular Biology, 26(10), 2260–2266. https://doi.org/10.1161/01.ATV.0000240290.70852.c0

Kular, J. K., Basu, S., & Sharma, R. I. (2014). The extracellular matrix: Structure, composition, age-related differences, tools for analysis and applications for tissue engineering. Journal of Tissue Engineering. https://doi.org/10.1177/2041731414557112

Article  PubMed  PubMed Central  Google Scholar 

Marcos-Contreras, O. A., de Martinez Lizarrondo, S., Bardou, I., Orset, C., Pruvost, M., Anfray, A., et al. (2016). Hyperfibrinolysis increases blood–brain barrier permeability by a plasmin- and bradykinin-dependent mechanism. Blood, 128(20), 2423–2434. https://doi.org/10.1182/blood-2016-03-705384

Article  CAS  PubMed  Google Scholar 

Mehta, A., Desai, S. R., Ko, Y., Liu, C., Dhindsa, D. S., Nayak, A., et al. (2020). Sex differences in Circulating soluble Urokinase-Type plasminogen activator receptor (suPAR) levels and adverse outcomes in coronary artery disease. Journal of the American Heart Association, 9(5). https://doi.org/10.1161/JAHA.119.015457

Onatsu, J., Taina, M., Mustonen, P., Hedman, M., Muuronen, A., Arponen, O., et al. (2017). Soluble urokinase-type plasminogen activator receptor predicts all-cause 5-year mortality in ischemic stroke and TIA. In Vivo, 31(3), 381–386. https://doi.org/10.21873/invivo.11070

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pietras, E. M. (2017). Inflammation: A key regulator of hematopoietic stem cell fate in health and disease. Blood, 130(15), 1693–1698. https://doi.org/10.1182/blood-2017-06-780882

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ploug, M., & Ellis, V. (1994). Structure—function relationships in the receptor for urokinase-type plasminogen activator comparison to other members of the Ly‐6 family and snake venom α‐neurotoxins. FEBS Letters, 349(2), 163–168. https://doi.org/10.1016/0014-5793(94)00674-1

Article  CAS  PubMed  Google Scholar 

Rasmussen, L. J. H., Caspi, A., Ambler, A., Danese, A., Elliott, M., Eugen-Olsen, J., et al. (2021). Association between elevated suPAR, a new biomarker of inflammation, and accelerated aging. The Journals of Gerontology: Series A, 76(2), 318–327. https://doi.org/10.1093/gerona/glaa178

Article  CAS  Google Scholar 

Rasmussen, L. J. H., Schultz, M., Gaardsting, A., Ladelund, S., Garred, P., Iversen, K., et al. (2017). Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer. International Journal of Cancer, 141(1), 191–199. https://doi.org/10.1002/ijc.30732

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reiser, J., Hayek, S. S., & Sever, S. (2026). The role of SuPAR and related proteins in kidney, heart diseases, and diabetes. Journal of Clinical Investigation, 136(1). https://doi.org/10.1172/JCI197141

Resnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., & Blasi, F. (2002). The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proceedings of the National Academy of Sciences, 99(3), 1359–1364. https://doi.org/10.1073/pnas.022652999

Article  CAS  Google Scholar 

Rosso, M. D. (2008). The plasminogen activation system in inflammation. Frontiers in Bioscience, Volume(13), 4667. https://doi.org/10.2741/3032

Article  Google Scholar 

Sajanti, A., Hellström, S., Bennett, C., et al. (2025). Soluble urokinase-type plasminogen activator receptor and inflammatory biomarker response with prognostic significance after acute neuronal injury – A prospective cohort study. Inflammation, 48(4), 2217–2229. https://doi.org/10.1007/s10753-024-02185-1

Article  CAS  PubMed  Google Scholar 

Saraswathibhatla, A., Indana, D., & Chaudhuri, O. (2023). Cell–extracellular matrix mechanotransduction in 3D. Nature Reviews Molecular Cell Biology, 24(7), 495–516. https://doi.org/10.1038/s41580-023-00583-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sehgal, T., Anand, A., Vijayabupathy, G., & Khan, M. (2024). Soluble urokinase plasminogen activator receptor: A useful marker for predicting mortality in COVID-19 patients. Cureus. https://doi.org/10.7759/cureus.74438

Article  PubMed